secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001171843-23-003310
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience shareholders re-elect directors, ratify auditor, approve say-on-pay at 2023 annual meeting
--------------------------------------------------------------------------------

- Katherine A. Eade and Thomas W. Loewald re-elected as Class II directors with over 24.5M and 25.5M votes for, respectively.
- Grant Thornton LLP ratified as independent auditor for FY2023 with 33.3M votes for, only 9,580 against.
- Non-binding advisory vote on executive compensation approved (26.6M for vs 531,708 against).
- Shareholders recommended a 1-year frequency for future say-on-pay votes (25.4M for 1 year); board adopted annual frequency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323003310/0001171843-23-003310-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323003310/f8k_051523.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-003310

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer